跳至主要内容
临床试验/NCT01723085
NCT01723085终止不适用

Anti-Mullerian Hormone Levels Variations Following an Open Myomectomy

Clinique Ovo1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
21
试验地点
1
主要终点
Anti-Mullerian Hormone levels variation

研究概览

简要总结

Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. It is well known that ovarian surgery for endometriosis lowers Anti-Mullerian hormone, but little is known for other surgeries. We seek to investigate the hormone variations before and after an open myomectomy.

Hypothesis: Anti-Mullerian hormone levels drop following surgery but return to normal levels in a few months

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18 to 42 years old
  • Requiring open myomectomy for any indication

排除标准

  • Incapable of informed consent
  • Use of hormonal contraception or Gonadotropin-releasing hormone agonists in the past 3 months
  • Woman over 42 years old
  • Post-menopause women
  • Positive B-human chorionic gonadotropin the day of surgery
  • Ovarian surgery (at the same time)
  • Pre-operative AMH below 0.3 ng/mL

结局指标

主要结局

Anti-Mullerian Hormone levels variation

时间窗: 6 months

Anti-Mullerian Hormone levels before and 6 months after surgery

次要结局

未报告次要终点

研究者

发起方
Clinique Ovo
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Anti-Mullerian Hormone Levels Before and After an... | 临床试验